Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021

SELL
$16.86 - $19.67 $222,771 - $259,899
-13,213 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$15.4 - $20.16 $74,274 - $97,231
-4,823 Reduced 26.74%
13,213 $229,000
Q2 2020

Jul 31, 2020

BUY
$18.24 - $21.45 $79,471 - $93,457
4,357 Added 31.85%
18,036 $329,000
Q1 2020

Apr 23, 2020

BUY
$16.28 - $25.63 $222,694 - $350,592
13,679 New
13,679 $275,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Altium Wealth Management LLC Portfolio

Follow Altium Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altium Wealth Management LLC with notifications on news.